IEQ Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

IEQ Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$730K	Sell	4,612 -2,938	-39%	-$397K	﹤0.01%	1239
2026 Q1	$964K	Buy	7,550 +2,825	+60%	+$353K	﹤0.01%	1064
2025 Q4	$576K	Buy	4,725 +266	+6%	+$30.5K	﹤0.01%	1265
2025 Q3	$447K	Sell	4,459 -80	-2%	-$7.21K	﹤0.01%	1349
2025 Q2	$376K	Buy	4,539 +170	+4%	+$13.6K	﹤0.01%	1293
2025 Q1	$354K	Sell	4,369 -222	-5%	-$19.8K	﹤0.01%	1122
2024 Q4	$414K	Sell	4,591 -389	-8%	-$37.7K	﹤0.01%	911
2024 Q3	$492K	Buy	4,980 +1	+0%	+$98	0.01%	754
2024 Q2	$462K	Sell	4,979 -3,471	-41%	-$311K	0.01%	684
2024 Q1	$802K	Buy	8,450 +2,559	+43%	+$237K	0.01%	508
2023 Q4	$526K	Sell	5,891 -94	-2%	-$6.98K	0.01%	567
2023 Q3	$437K	Sell	5,985 -81	-1%	-$6.47K	0.01%	608
2023 Q2	$505K	Sell	6,066 -732	-11%	-$61.2K	0.01%	542
2023 Q1	$518K	Buy	6,798 +593	+10%	+$49.2K	0.01%	555
2022 Q4	$515K	Sell	6,205 -31,149	-83%	-$2.52M	0.01%	508
2022 Q3	$2.96M	Buy	37,354 +31,956	+592%	+$2.69M	0.08%	173
2022 Q2	$401K	Sell	5,398 -262	-5%	-$19.7K	0.01%	526
2022 Q1	$509K	Hold	5,660	–	–	0.01%	497
2021 Q4	$634K	Sell	5,660 -6,652	-54%	-$802K	0.01%	405
2021 Q3	$1.55M	Sell	12,312 -190	-2%	-$24.5K	0.04%	223
2021 Q2	$1.69M	Buy	12,502 +10,103	+421%	+$1.33M	0.05%	193
2021 Q1	$325K	Buy	+2,399	New	+$359K	0.01%	353
2020 Q4	–	Sell	-11,893	Closed	-$1.32M	–	396
2020 Q3	$1.32M	Buy	+11,893	New	+$1.33M	0.07%	147

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

IEQ Capital's XBI Position: Q2 2026 in Review

IEQ Capital reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 39% in Q2 2026, selling an estimated $397K and leaving 4,612 shares worth $730K. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

IEQ Capital first reported a position in XBI in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.96M in Q3 2022. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

IEQ Capital held 4,612 shares of State Street SPDR S&P Biotech ETF worth $730K as of Q2 2026.
IEQ Capital sold 2,938 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $397K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1239 holding.
IEQ Capital first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 23 quarters since.
IEQ Capital's State Street SPDR S&P Biotech ETF position peaked at $2.96M in Q3 2022.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.